Key result
High baseline C-reactive protein independently predicted mortality in patients with non-ischemic left ventricular dysfunction compared to low CRP.
Why the study?
Does high baseline C-reactive protein predict mortality in patients with non-ischemic left ventricular dysfunction?
Cohort (n=203)
Does high baseline C-reactive protein predict mortality in patients with non-ischemic left ventricular dysfunction?
Elevated baseline CRP levels independently predict increased mortality in patients with non-ischemic left ventricular dysfunction.
Answers are grounded in this paper and cite their sources.
May refine risk stratification in non-ischemic LV dysfunction; hypothesis-generating pending prospective validation.
C-reactive protein (CRP) has been associated with atherosclerotic complications, and we hypothesized that CRP levels might also predict death in non-ischemic patients with left ventricular dysfunction. Two hundred and three patients with non-ischemic left ventricular dysfunction undergoing cardiac catheterization were included and were followed for 2.4 +/- 1.4 years to determine the incidence of fatal events. Death occurred in 15% of patients with low CRP (1st and 2nd tertiles) and 30% of patients with high CRP (3rd tertile). After adjustment for 11 covariates, high CRP (p = 0.037, hazard ratio = 2.0) significantly and independently predicted mortality. Even in the absence of coronary artery disease, patients with left ventricular dysfunction are at increased risk of mortality based on their baseline CRP concentrations.
No takes yet. Share an insight, caveat, or question.
Ronnow et al. (2005) conducted a cohort in Non-ischemic cardiomyopathy (n=203). High C-reactive protein (3rd tertile) vs. Low C-reactive protein (1st and 2nd tertiles) was evaluated on Death (HR 2.0, p=0.037). High baseline C-reactive protein independently predicted mortality in patients with non-ischemic left ventricular dysfunction compared to low CRP.
Synapse has enriched 10 related papers. Consider them for comparative context: